Mulmit

Scinai Immunotherapeutics Ltd.Scinai Immunotherapeutics Ltd.

SCNI Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,311,000-7,542,000-8,307,000
2024-12-31658,000-8,638,0004,796,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-16GERMAIN MARK120,000,000
2026-06-16Reichman AmirChief Executive Officer400,000,000

8-K events

FiledItems
2023-06-08Entry into a material agreement
2023-05-11Officer or director change
2023-05-04Delisting or listing-standard notice
2023-05-04Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.